Status
Lab Tested
Retatrutide
Select Size
₱3,500
Out of Stock
An investigational triple-receptor (GLP-1 / GIP / Glucagon) agonist peptide studied in metabolic research.
Key Benefits
- Triple receptor agonist (GLP-1 + GIP + Glucagon)
- Studied for body-weight reduction in clinical trials
- Researched for fat-oxidation pathways
- Examined for appetite regulation
- Investigated for metabolic markers
Certificate of Analysis
Independently tested by Janoshik Analytical — every result is verifiable.
Each report is hosted by Janoshik Analytical. Enter the verification key at janoshik.com/verify to confirm authenticity independently.
About This Peptide
Detailed information about Retatrutide.
Retatrutide is an investigational triple-agonist peptide that targets the GLP-1, GIP, and glucagon receptors. It has been evaluated in clinical research for its effects on body weight and metabolic markers.
Retatrutide is supplied as a lyophilised powder vial and is lab tested to verify identity and purity. Every batch comes with a Certificate of Analysis (COA) so you can verify exactly what you're receiving. This product falls under the Weight Management category.
For laboratory and research use only. Not for human or veterinary consumption. These products are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the U.S. FDA or the Philippine FDA.
